Sprout’s Low Libido Drug Flibanserin Going To FDA Advisory Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
Originally developed by Boehringer Ingelheim, serotonin agonist and antagonist flibanserin is in position to be the first FDA-approved drug for female sexual desire disorders.